Childrens Fexofenadine Hydrochloride Suspension
NDC Package 51672-2141-1
Package Information
Childrens Fexofenadine Hydrochloride (fexofenadine hydrochloride) suspension is shake well before usinguse only with enclosed dosing cupNote: mL = millilitersadults and children 12 years of age and overtake 10 mL every 12 hours; do not take more than 20 mL in 24 hourschildren 2 to under 12 years of agetake 5 mL every 12 hours; do not take more than 10 mL in 24 hourschildren under 2 years of ageask a doctoradults 65 years of age and olderask a doctorconsumers with kidney diseaseask a doctor. This formulation utilizes a suspension delivery system. Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 51672-2141 and is authorized under FDA application ANDA208123.
Identification & Billing
- RxCUI: 997491 - fexofenadine HCl 30 MG in 5 mL Oral Suspension
- RxCUI: 997491 - fexofenadine hydrochloride 6 MG/ML Oral Suspension
- RxCUI: 997491 - fexofenadine HCl 30 MG per 5 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51672 - Sun Pharmaceutical Industries, Inc.
- 51672-2141 - Childrens Fexofenadine Hydrochloride
- 51672-2141-1 - 1 BOTTLE in 1 CARTON / 240 mL in 1 BOTTLE
- 51672-2141 - Childrens Fexofenadine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51672-2141). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51672-2141-1 identifies a specific commercial package of 1 bottle in 1 carton / 240 ml in 1 bottle of Childrens Fexofenadine Hydrochloride Allergy, a human over the counter drug labeled by Sun Pharmaceutical Industries, Inc.. This suspension is formulated for oral use and contains fexofenadine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on January 24, 2024. The current certification is valid through December 31, 2027.
How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672214101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.